Tratamiento con octreotide (SMS 201-995) en un caso de tumor carcinoide intestinal
Palabras clave : 
Carcinoid tumor/drug therapy
Hydroxyindoleacetic acid/urine
Jejunal neoplasms/surgery
Fecha de publicación: 
1991
Editorial : 
Elsevier España
ISSN: 
0014-2565
Cita: 
Goñi F, Oleaga A, Goñi MJ, Monreal M, Yoldi A, González A, et al. Tratamiento con octreotide (SMS 201-995) en un caso de tumor carcinoide intestinal. Rev Clin Esp. 1991 Nov;189(7):331-334
Resumen
Over the past few years the usefulness of some somatostatin's analogues in the treatment of intestinal tract endocrine tumors has been demonstrated. Notwithstanding, the results obtained are variable. The case of a carcinoid tumor with a hepatic metastasis is presented and its clinical as well as its biochemical and its morphological results are evaluated after treatment with octreotide over a seven months period. It is important to highlight the great clinical improvement obtained at the beginning of treatment. Treatment was not effective in the control of tumor progression. After the injection of such a drug, a decrease in serotonin and 5-hydroxy-indoleacetic acid serum levels was observed as well as a reduction in the urinary metabolite. It is concluded that octreotide is very useful for the symptomatic treatment of carcinoid syndrome.

Ficheros en este registro:
Fichero: 
Rev_clin_esp_1991_189(7)_331-4.pdf
Descripción: 
Tamaño: 
272,5 kB
Formato: 
Adobe PDF


Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.